Comparison of dose-dense and every-3-week taxane in the neoadjuvant treatment of ovarian, fallopian tube, and primary peritoneal cancer

Emily Hinchcliff,Ivy Wilkinsonryan,Allison Gockley,K M Esselen,Andrea R Hagemann,M Auer,Y Tao,David G Mutch,K Fuh,Neil S Horowitz

GYNECOLOGIC ONCOLOGY（2015）

引用 0|浏览17

暂无评分

摘要

Objectives: To compare surgical outcomes and survival between women treated with neoadjuvant platinum and weekly (DD) or every 3-week (q3wk) taxane for ovarian, fallopian tube, or primary peritoneal cancer.

查看译文

关键词

neoadjuvant treatment,ovarian,taxane,cancer,dose-dense

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要